About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

Luye Pharma’s Analgesic Drug Mimeixin (Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-Release Tablets) Approved for Marketing in ...


Shanghai, July 4, 2024 — Luye Pharma Group announced that its Mimeixin (oxycodone hydrochloride and naloxone hydrochloride sustained-release tablets) was approved for marketing by China's National Medical Products Administration ...

July 04,2024

Luye Pharma’s Manufacturing Facility for Paliperidone Palmitate Extended-release Injectable Suspension (LY03010) Passes FDA’s PAI with No ...

Shanghai, June 27, 2024 - Luye Pharma Group today announced that it has recently received an Establishment Inspection Report from the U.S. Food and Drug Administration (FDA) indicating that the manufacturing facility of Paliperidone Palmitate ...

June 27,2024

Read More


Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company